Certified Service Providers

Protein- and antibody-based therapeutics have revolutionized medicine. The first protein-based therapeutic, insulin, was administered to diabetic patients to regulate blood sugar in 1922. Since then, roughly 60 more proteins have been approved for clinical use by the United States' Food and Drug Administration (FDA).

Antibody-based therapeutics have become increasingly popular since the first one was approved by the FDA in 1986 (Figure 1), with the 100th therapeutic antibody approved in 2021. Protein- and antibody-based therapeutics help treat a plethora of human diseases, such as cancer, blood disorders, rheumatoid arthritis, psoriasis, multiple sclerosis, high cholesterol, and systemic lupus erythematosus. They are also used to manage weight gain, growth, and pregnancies.

RayBiotech has a comprehensive catalog of products and services to advance drug discovery, from off-the-shelf arrays to screen for drug candidates to custom assays and services. Our comprehensive analytical services ensure compliance with CLIA, good clinical laboratory practices (GCLP), good laboratory practice (GLP), and current good manufacturing practice (cGMP) standards as well as current regulatory guidance documents based on industry requirements.